2022
DOI: 10.1155/2022/5390685
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR-Based Programmable Nucleic Acid-Binding Protein Technology Can Specifically Detect Fatal Tropical Disease-Causing Pathogens

Abstract: Diagnostic approaches capable of ultrasensitive pathogen detection from low-volume clinical samples, running without any sophisticated instrument and laboratory setup, are easily field-deployable, inexpensive, and rapid, and are considered ideal for monitoring disease progression and surveillance. However, standard pathogen detection methods, including culture and microscopic observation, antibody-based serologic tests, and primarily polymerase chain reaction (PCR)-oriented nucleic acid screening techniques, h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 109 publications
0
2
0
1
Order By: Relevance
“…INAAT techniques are ideally suited for adaptation to POC and field deployable settings [ 89 ]. A wide range of technologies have been developed as promising candidates for POC devices which could be used in combination with INAAT and are briefly discussed below.…”
Section: Point Of Care Diagnosticsmentioning
confidence: 99%
“…INAAT techniques are ideally suited for adaptation to POC and field deployable settings [ 89 ]. A wide range of technologies have been developed as promising candidates for POC devices which could be used in combination with INAAT and are briefly discussed below.…”
Section: Point Of Care Diagnosticsmentioning
confidence: 99%
“…También se han detectado citoquinas que se visualizan con LFA. 46 La implementación a gran escala de nuevas pruebas diagnósticas en aplicaciones clínicas y en salud pública todavía es limitada por una serie de factores: la falta de soluciones estandarizadas, los requisitos técnicos de los laboratorios, altos costos asociados con la implementación y el mantenimiento de estas tecnologías moleculares, la infraestructura de Internet y la computación en la nube. 47 Esperamos que abordar estas barreras mejore los resultados de los pacientes, pero aún se necesita una verdadera prueba POC para superar los desafíos restantes, como la preparación de muestras y las demandas de recursos humanos.…”
Section: Dispositivosunclassified
“…In the past decade, the CRISPR-Cas system has been developed into multiple editing tools (Abdelrahman et al 2021 ; Singh et al 2022 ). Recently, Rahman et al reviewed the application of CRISPR-Cas-based molecular technologies in the diagnosis of several tropical diseases (Rahman et al 2022 ). According to effector modules, the CRISPR-Cas system is divided into type I and type II (Koonin and Makarova 2019 ).…”
Section: Introductionmentioning
confidence: 99%